In February 2022, Sarepta Therpeutics (US) announced a collaboration to use GenEdit’s NanoGalaxy platform and Sarepta’s gene editing technology to develop gene editing therapeutics to treat neuromuscular diseases.Northbrook, IL 60062 — (SBWIRE) — 10/27/2022 — Gene Therapy Market is projected to reach USD 17.2 billion by 2027 from USD 7.3 billion in 2022…
Read More